Digoxin and ouabain increase the synthesis of cholesterol in human liver cells

Cellular and Molecular Life Sciences

Volumn 66, Issue 9, 2009, Pages 1580-1594

  Campia, I ^a   Gazzano, E ^a   Pescarmona, G ^a   Ghigo, D ^a   Bosia, A ^a   Riganti, C ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

3 hydroxy 3 methylglutaryl coenzyme A reductase; Cholesterol; Digoxin; Ouabain; SREBP cleavage activating protein; Sterol regulatory element binding proteins

Indexed keywords

CHOLESTEROL; DIGOXIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; OUABAIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 2;

ARTICLE; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LIVER CELL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN EXPRESSION;

CARDIOTONIC AGENTS; CHOLESTEROL; DIGOXIN; ENZYME INHIBITORS; HEPATOCYTES; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOVASTATIN; OUABAIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; UBIQUINONE;

STROPHANTHUS GRATUS;

EID: 67649540886     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-009-9018-5     Document Type: Article

References (33)

1. Kaplan, J. H. (2002) Biochemistry of Na,K-ATPase. Annu. Rev. Biochem. 71, 511-535
2. Takara, K., Takagi, K., Tsujimoto, M., Ohnishi, N. and Yokoyama, T. (2003) Digoxin up-regulates multidrug resistance transporter (MDR1) mRNA and simultaneously downregulates steroid xenobiotic receptor mRNA. Biochem. Biophys. Res. Commun. 306, 116-120
3. Kau, M., Kan, S., Wang, J. and Wang, P. S. (2005) Inhibitory effects of digoxin and ouabain on aldosterone synthesis in human adrenocortical NCI-H295 cells. J. Cell. Physiol. 205, 393-401
4. Neri, G., De Toni, R., Tortorella, C., Rebuffat, P., Bova, S., Cargnelli, G., Petrelli, L., Spinazzi, R. and Nussdorfer, G. G. (2006) Ouabain chronic infusion enhances the growth and steroidogenic capacity of rat adrenal zona glomerulosa: The possible involvement of the endothelin system. Int. J. Mol. Med. 18, 315-319
5. Pu, H.,Wang, S., Tseng, C., Huang, H., Lin, C., Hsu, J., Chen, M.,Chow,Y. andWang, P. S. (2006) Mechanisms of digoxin and digitoxin on the production of corticosterone in zona fasciculata-reticularis cells of ovariectomized rats. J. Cell. Biochem. 97, 303-313.
6. Espenshade, P. J. and Hughes,A. L. (2007) Regulation of sterol synthesis in eukaryotes. Annu. Rev. Genet. 41, 401-427
7. Liao, J. K. and Laufs, U. (2005) Pleiotropic effects of statins. Annu. Rev. Pharmacol. Toxicol. 45, 89-118
8. Horton, J. D., Goldstein, J. L. and Brown, M. S. (2002). SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver J. Clin. Invest. 109, 1125-1131
9. Goldstein, J. L., DeBose-Boyd, R. A. and Brown, M. S. (2006) Protein sensors for membrane sterols. Cell 124, 35-46
10. Nakanishi, M., Goldstein, J. L. and Brown, M. S. (1988) Multivalent control of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Mevalonate-derived product inhibits translation of mRNA and accelerates degradation of enzyme. J. Biol. Chem. 263, 8929-8937
11. Ravid,T.,Doolman, R.,Avner,R., Harats,D. and Roitelman, J (2000). The ubiquitin-proteasome pathway mediates the regulated degradation of mammalian 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J. Biol. Chem. 275, 35840-35847
12. Edwards, P.A., Show-Fung, L. and Fogelman, A. M. (1986)The effect of glucagon on the synthesis and degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase. J. Lipid Res. 27, 398-403
13. Allain, C. C., Poon, L. S., Chan, C. S., Richmond,W. and Fu, P. C. (1974) Enzymatic determination of total serum cholesterol. Clin. Chem. 20, 470-475
14. Seifert, S. Cand Lucas, J. J. (1988) Incorporation of mevalonate into dolichol and other isoprenoids during estrogen-induced chick oviduct differentiation. Biochim. Biophys. Acta 962, 16 - 24
15. Riganti, C., Doublier, S., Costamagna, C., Aldieri, E., Pescarmona, G., Ghigo, D. and Bosia, A. (2008) Activation of NF-kB byRhoAsilencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells. Mol. Pharmacol. 74, 476-484
16. Philipp, B.W. and Shapiro, D. J. (1979) Improved methods for the assay and activation of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Lipid Res. 20, 588-593
17. Lee, M. Y.,Moon, J. S., Park, S.W., Koh, Y. K.,Ahn, Y. H. and Kim, K. S. (2009) KLF5 enhances SREBP-1 action in androgen-dependent induction of fatty acid synthase in prostate cancer cells. Biochem. J. 417, 313-322
18. Vallett, S. M., Sanchez, H. B., Rosenfeld, J. M. and Osborne, T. F. (1996) A direct role for sterol regulatory element binding protein in activation of 3-hydroxy-3-methylglutaryl coenzyme A reductase gene. J. Biol. Chem. 271, 12247-12253
19. Brown, A. J., Sun, L., Feramisco, J. D., Brown, M. S. and Goldstein, J. L. (2002) Cholesterol addition to ER membranes alters conformation of SCAP, the SREBP escort protein that regulates cholesterol metabolism. Mol. Cell 10, 237-245.
20. Bergstrom, J.D., Dufresne, C., Bills,G. F., Nallin-Omstead, M. and Byrne, K. (1995) Discovery, biosynthesis, and mechanism of action of the zaragozic acids: Potent inhibitors of squalene synthase. Annu. Rev. Microbiol. 49, 607-639
21. Valente, R. C., Capella, L. S., Monteiro, R. Q., Rumjanek, V. M., Lopes, A. G. and Capella, M. A. (2003) Mechanisms of ouabain toxicity. FASEB J. 17, 1700-1702
22. Schrier, R. W., Abdallah, J. G., Weinberger, H. H. D. and Abraham,W. T. (2000)Therapy of heart failure.Kidney Int. 57, 1418-1425
23. Adorisio, R., De Luca, L., Rossi, J. and Gheorghiade, M. (2006) Pharmacological treatment of chronic heart failure. Heart Fail. Rev. 11, 109-123
24. Hauptman, P. J. and Kelly, R. A. (1999) Digitalis. Circulation 99, 1265-1270
25. Haynes, K., Heitjan, D. F., Kanetsky, P. A. and Hennessy, S. (2008) Declining public health burden of digoxin toxicity from 1991 to 2004. Clin. Pharmacol. Ther. 84, 90-94
26. Schoner,W. (2002) Endogenous cardiac glycosides, a new class of steroid hormones. Eur. J. Biochem. 269, 2440-2448
27. Hansen,O. (2003) No evidence for a role in signal-transduction of Na+/K+-ATPase interaction with putative endogenous ouabain. Eur. J. Biochem. 270, 1916-1919
28. DeBose-Boyd, R. A., Brown, M. S., Wei-Ping, L., Nohturfft, A., Goldstein, J. L. and Espenshade, P. J. (1999) Transportdependent proteolysis of SREBP: Relocation of site-1 protease from Golgi toERobviates the need for SREBP transport to Golgi. Cell 99, 703-712.
29. Amemiya-Kudo, M., Shimano, H., Hasty, A. H., Yahagi, N., Yoshikawa, T., Matsuzaka, T., Okazaki, H., Tamura, Y., Iizuka, Y., Ohashi, K., Osuga, J., Harada, K., Gotoda, T., Sato, R., Kimura, S., Ishibashi, S. and Yamada, N. (2002) Transcriptional activities of nuclear SREBP-1a, -1c, and -2 to different target promoters of lipogenic and cholesterogenic genes. J. Lipid Res. 43, 1220-1235
30. Ngo, T. T., Bennett, M. K., Bourgeois, A. L., Toth, J. I. and Osborne, T. F. (2002)A role for cyclic AMP response elementbinding protein (CREB) but not the highly similar ATF-2 protein in sterol regulation of the promoter for 3-hydroxy-3-methylglutaryl coenzyme A reductase. J. Biol. Chem. 277, 33901-33905
31. Pallottini, V., Guantario, B., Martini, C., Totta, P., Filippi, I, Carraro, F. and Trentalance, A. (2008) Regulation of HMGCoA reductase expression by hypoxia. J. Cell. Biochem. 104, 701-709
32. Saini, H. K., Arneja, A. S. and Dhalla, N. S. (2004) Role of cholesterol in cardiovascular dysfunction. Can. J. Cardiol. 20, 333-346
33. Ghandehari, H., Kamal-Bahl, S. and Wong, N. D. (2008) Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004. Am. Heart J. 156, 112-119